Epigeneties: Relations to disease and laboratory findings

被引:18
作者
Maekawa, Masato [1 ]
Watanabe, Yoshihisa [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Lab Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
关键词
epigenetics; methylation; histone deacetylation; expression; laboratory data; diagnosis; prognosis; cancer;
D O I
10.2174/092986707782023172
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigenetics is a postmeiotic modification of gene expression that is independent of the primary DNA sequence. DNA methylation, methylated DNA binding proteins, and historic modification-related enzymes are associated with epigenetics. Abnormalities in DNA methylation of CpG islands which are important for gene expression control, affect gene expression, which may influence carcinogenesis, aging, and other diseases. Aberrant DNA methylation occurs with aging, inflammation, viral infection, and carcinogenesis. DNA methylation can be evaluated for molecular analysis for diagnosis of early cancer. It is also important for laboratory diagnosis by using classic and authentic laboratory tests because the tests can be affected by epigenetics-controlled gene expression. It is also related to the effectiveness of therapeutic agents affecting DNA methylation and histone deacetylation, and the strategy in search of genetic abnormality for epigenetic as well as genetic error.
引用
收藏
页码:2642 / 2653
页数:12
相关论文
共 191 条
[1]   Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon [J].
Abril, E ;
Mendez, RE ;
Garcia, A ;
Serrano, A ;
Cabrera, T ;
Garrido, F ;
RuizCabello, F .
TISSUE ANTIGENS, 1996, 47 (05) :391-398
[2]  
ADELE M, 2005, HUM MOL GENET, V14, P3
[3]  
Ahuja N, 1998, CANCER RES, V58, P5489
[4]   Colorectal cancer "Methylator phenotype": Fact or artifact?' [J].
Anacleto, C ;
Leopoldino, AM ;
Rossi, B ;
Soares, FA ;
Lopes, A ;
Rocha, JCC ;
Caballero, O ;
Camargo, AA ;
Simpson, AJG ;
Pena, SDJ .
NEOPLASIA, 2005, 7 (04) :331-335
[5]  
Anttila S, 2003, CANCER RES, V63, P8623
[6]   Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines [J].
Arnold, CN ;
Goel, A ;
Boland, CR .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (01) :66-73
[7]  
BASU M, 1991, Glycobiology, V1, P527, DOI 10.1093/glycob/1.5.527
[8]  
Battagli C, 2003, CANCER RES, V63, P8695
[9]  
Benson K, 1991, Immunohematology, V7, P89
[10]   The mammalian epigenome [J].
Bernstein, Bradley E. ;
Meissner, Alexander ;
Lander, Eric S. .
CELL, 2007, 128 (04) :669-681